Skip to main content
NCBI home page
British Heart Journal logoLink to British Heart Journal
. 1986 Feb;55(2):181–186. doi: 10.1136/hrt.55.2.181

Effect of long term treatment with metoprolol and sotalol on ventricular repolarisation measured by use of transoesophageal atrial pacing.

C Blomström-Lundqvist, M Dohnal, I Hirsch, A Lindblad, A Hjalmarson, S B Olsson, N Edvardsson
PMCID: PMC1232115  PMID: 3080012

Abstract

The effects of long term (4 weeks) treatment with oral metoprolol (100 mg twice daily) and sotalol (160 mg twice daily) on ventricular repolarisation time were compared in a double blind crossover study in 20 patients post-infarction. For QT interval studies transoesophageal atrial pacing was performed at a cycle length of 800 ms. Sotalol prolonged the QT interval by 5-7% compared with metoprolol. The prolongation reflects a change in the repolarisation time because there was no change in the QS interval. Measurements of heart rate at rest and during bicycle exercise indicated that metoprolol and sotalol in the doses selected were equipotent as beta blockers. Transoesophageal atrial pacing is a simple non-invasive method with few and mild side effects that is well suited to drug studies.

Full text

PDF
181

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Ablad B., Borg K. O., Carlsson E., EK L., Johnson G., Malmfors T., Regårdh C. G. A survey of the pharmacological properties of metoprolol in animals and man. Acta Pharmacol Toxicol (Copenh) 1975;36(Suppl 5):7–23. doi: 10.1111/j.1600-0773.1975.tb03318.x. [DOI] [PubMed] [Google Scholar]
  2. Benson D. W., Jr, Sanford M., Dunnigan A., Benditt D. G. Transesophageal atrial pacing threshold: role of interelectrode spacing, pulse width and catheter insertion depth. Am J Cardiol. 1984 Jan 1;53(1):63–67. doi: 10.1016/0002-9149(84)90684-2. [DOI] [PubMed] [Google Scholar]
  3. Blichert-Toft M. Current principles in diagnosis and surgical management of breast cancer. Dan Med Bull. 1983 Dec;30 (Suppl 2):18–26. [PubMed] [Google Scholar]
  4. Cobbe S. M., Hoffman E., Ritzenhoff A., Brachmann J., Kübler W., Senges J. Action of sotalol on potential reentrant pathways and ventricular tachyarrhythmias in conscious dogs in the late postmyocardial infarction phase. Circulation. 1983 Oct;68(4):865–871. doi: 10.1161/01.cir.68.4.865. [DOI] [PubMed] [Google Scholar]
  5. Dick M., 2nd, Campbell R. M., Jenkins J. M. Thresholds for transesophageal atrial pacing. Cathet Cardiovasc Diagn. 1984;10(5):507–513. doi: 10.1002/ccd.1810100515. [DOI] [PubMed] [Google Scholar]
  6. Edvardsson N., Hirsch I., Emanuelsson H., Pontén J., Olsson S. B. Sotalol-induced delayed ventricular repolarization in man. Eur Heart J. 1980 Oct;1(5):335–343. doi: 10.1093/eurheartj/1.5.335. [DOI] [PubMed] [Google Scholar]
  7. Edvardsson N., Olsson S. B. Effects of acute and chronic beta-receptor blockade on ventricular repolarisation in man. Br Heart J. 1981 Jun;45(6):628–636. doi: 10.1136/hrt.45.6.628. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Fitzgerald J. D. Beta blocking drugs as anti-arrhythmic agents. Int J Clin Pharmacol Biopharm. 1975 Apr;11(3):235–244. [PubMed] [Google Scholar]
  9. Jenkins J. M., Dick M., Collins S., O'Neill W., Campbell R. M., Wilber D. J. Use of the pill electrode for transesophageal atrial pacing. Pacing Clin Electrophysiol. 1985 Jul;8(4):512–527. doi: 10.1111/j.1540-8159.1985.tb05853.x. [DOI] [PubMed] [Google Scholar]
  10. Milne J. R., Camm A. J., Ward D. E., Spurrell R. A. Effect of intravenous propranolol on QT interval. A new method of assessment. Br Heart J. 1980 Jan;43(1):1–6. doi: 10.1136/hrt.43.1.1. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Nathan A. W., Hellestrand K. J., Bexton R. S., Ward D. E., Spurrell R. A., Camm A. J. Electrophysiological effects of sotalol--just another beta blocker? Br Heart J. 1982 Jun;47(6):515–520. doi: 10.1136/hrt.47.6.515. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Prichard B. N. The use of beta adrenergic blocking drugs in cardiovascular disease. Scott Med J. 1976 Oct;21(4):182–187. doi: 10.1177/003693307602100407. [DOI] [PubMed] [Google Scholar]
  13. Raine A. E., Vaughan Williams E. M. Adaptation to prolonged beta-blockade of rabbit atrial, purkinje, and ventricular potentials, and of papillary muscle contraction. Time-course of development of and recovery from adaptation. Circ Res. 1981 Jun;48(6 Pt 1):804–812. doi: 10.1161/01.res.48.6.804. [DOI] [PubMed] [Google Scholar]
  14. Singh B. N., Jewitt D. E. Beta-adrenergic receptor blocking drugs in cardiac arrhythmias. Drugs. 1974;7(6):426–461. doi: 10.2165/00003495-197407060-00004. [DOI] [PubMed] [Google Scholar]
  15. Singh B. N., Vaughan Williams E. M. A third class of anti-arrhythmic action. Effects on atrial and ventricular intracellular potentials, and other pharmacological actions on cardiac muscle, of MJ 1999 and AH 3474. Br J Pharmacol. 1970 Aug;39(4):675–687. doi: 10.1111/j.1476-5381.1970.tb09893.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Strauss H. C., Bigger J. T., Jr, Hoffman B. F. Electrophysiologial and beta-receptor blocking effects of MJ 1999 on dog and rabbit cardiac tissue. Circ Res. 1970 Jun;26(6):661–678. doi: 10.1161/01.res.26.6.661. [DOI] [PubMed] [Google Scholar]
  17. Williams E. M., Raine A. E., Cabrera A. A., Whyte J. M. The effects of prolonged beta-adrenoceptor blockade on heart weight and cardiac intracellular potentials in rabbits. Cardiovasc Res. 1975 Sep;9(5):579–592. doi: 10.1093/cvr/9.5.579. [DOI] [PubMed] [Google Scholar]

Articles from British Heart Journal are provided here courtesy of BMJ Publishing Group

RESOURCES